September 15, 2025
reOpenTest Expands Manufacturing Capacity to Meet Global Demand
A major investment in our NomoFlow™-powered facility will significantly increase output, ensuring supply chain stability for our global partners.
Read More →Engineers of Reliability.
reOpenTest exists to provide a verifiable, trusted starting point for every critical diagnostic decision.
We believe true reliability is engineered at the source, not inspected in at the end. Our proprietary NomoFlow™ platform fundamentally redesigns the manufacturing process to ensure unmatched consistency and performance. It is the physical basis for every promise we make.
Explore Our Technology Platform →Our operations adhere to the highest global standards. From raw material sourcing to final lot release, every step is governed by a rigorous Quality Management System, ensuring every product you receive is safe, effective, and compliant.
Review Our Quality & Compliance →We are a collective of pragmatic engineers, meticulous scientists, and dedicated professionals united by a single purpose: to eliminate uncertainty in the world of diagnostics. We are committed to building a stronger foundation for global health.
Join Our Mission →September 15, 2025
A major investment in our NomoFlow™-powered facility will significantly increase output, ensuring supply chain stability for our global partners.
Read More →August 22, 2025
Our latest multiplex assay for Flu A/B, RSV, and COVID-19 has received its CE mark, providing a critical tool for differential diagnosis.
Read More →We are looking for like-minded distributors and strategic partners to bring the power of the NomoFlow™ platform to users across the globe. If you believe in providing truly reliable diagnostic solutions for your customers, we invite you to join our network.